產(chǎn)品詳情
簡單介紹：
Anti-Adracalin抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Adracalin抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Adracalin
Cat. Number:
Anti-Adracalin抗體KL-11807R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Aladin (Adracalin) belongs to a family of WD repeat-containing proteins. These proteins have a wide variety of functions, Anti-Adracalin抗體including signal transduction regulation, RNA processing and transcription. Aladin plays a role in peripheral and central nervous system development. It is widely expressed, with the highest expression seen in pituitary gland, corpus callosum, cerebellum, adrenal gland and gastrointestinal structures. Defects in Aladin cause the autosomal recessive disorder achalasia-addisonianism-alacrima (triple A) syndrome. Triple A syndrome is characterized by achalasia, alacrima and adrenocortico-tropin-resistant adrenal insufficiency. Robust expression in neural systems associated with cognitive, motor and sensory functions is consistent with the myriad of symptoms experienced by patients with triple A syndrome.
Also known as:
Anti-Adracalin抗體AAA; AAAS; AAASb; Achalasia adrenocortical insufficiency alacrimia (Allgrove triple A); Achalasia adrenocortical insufficiency alacrimia; ADRACALA; Aladin; Allgrove triple A; DKFZp586G1624; GL003; AAAS_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, .
●
Immunogen:Anti-Adracalin抗體 KLH conjugated synthetic peptide derived from human Adracalin.
●
Predicted Molecular Weight: 60kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
Anti-Adracalin抗體WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl889Ra01 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Rb51 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl890Ca01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Mu01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Po01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Ra01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl891Hu01 花生四烯酸-15-脂加氧酶(ALOX15)多克隆抗體 Polyclonal Antibody to Arachidonate-15-Lipoxygenase (ALOX15)
kl895Hu01 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl895Ra01 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl896Po01 半胱氨酸蛋白酶抑制劑3(CST3)多克隆抗體 Polyclonal Antibody to Cystatin 3 (CST3)
kl897Hu01 血紅蛋白μ(HBμ)多克隆抗體 Polyclonal Antibody to Hemoglobin Mu (HBm)
kl899Ca01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Mu01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Po01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Ra01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Rb51 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl901Hu01 多巴胺受體D3(DRD3)多克隆抗體 Polyclonal Antibody to Dokline Receptor D3 (DRD3)
kl902Hu01 耐酒石酸酸性磷酸酶(ACP5)多克隆抗體 Polyclonal Antibody to Acid Phosphatase 5, Tartrate Resistant (ACP5)
